Acupuncture for the treatment of vulvodynia: A randomized wait-list controlled pilot study

Vulvodynia is a gynecologic condition that affects between 8.3% and 16% of American women, characterized by chronic pain in the vulvar region and dyspareunia (pain during sexual intercourse). Currently, there is no consistently effective standardized treatment for this condition, which motivated the investigators to examine the potential of acupuncture as a therapeutic alternative.

This randomized controlled pilot study was conducted with 36 women diagnosed with vulvodynia. Participants were randomly divided into two groups: 18 received acupuncture and 18 were placed on a wait list as a control group. The acupuncture protocol consisted of 10 sessions performed twice weekly for 5 consecutive weeks.

The treatment followed a standardized protocol using specific points: GV-20 (Baihui), CV-2 (Qugu), CV-4 (Guanyuan), KI-11 (Henggu), ST-30 (Qichong), LI-4 (Hegu), SP-6 (Sanyinjiao), and LR-3 (Taichong). Bilateral points were needled on both sides. The investigators emphasized obtaining De Qi (the characteristic needling sensation), kept the needles in place for 30 minutes, and performed manual stimulation three times during each session.

Primary outcomes were measured using the McGill Pain Questionnaire (short form) to assess the intensity of vulvar pain, while sexual function was assessed as a secondary outcome using the Female Sexual Function Index (FSFI). The study demonstrated that, despite the small sample size, the power calculation indicated that the number of participants was adequate to detect significant differences in the primary variable.

Results showed that the acupuncture-treated group had a statistically significant reduction in both vulvar pain and dyspareunia compared with the control group. In addition, aggregate FSFI scores showed significant improvement in overall sexual function in women who received acupuncture. However, specific aspects of sexuality such as sexual desire, arousal, lubrication, orgasmic capacity, and sexual satisfaction did not show statistically significant improvements, although they did show positive trends.

This was the first randomized controlled clinical trial to specifically examine the use of acupuncture for vulvodynia. The protocol proved feasible and well tolerated, with 100% of participants completing treatment. The standardized approach was deliberately chosen by the investigators, who opted not to use sham (placebo) acupuncture, arguing that any point on the body can function as an Ashi point and have a therapeutic effect.

The clinical implications are promising for women suffering from this debilitating condition. Acupuncture offers a non-pharmacologic alternative with the potential to significantly reduce pain and improve sexual quality of life. The treatment was shown to be safe, with no adverse events reported, and with high patient adherence.

Limitations include the small sample size, the pilot nature of the study, the absence of blinding, and the lack of a placebo group with sham acupuncture. Follow-up was limited to the treatment period, without evaluation of long-term effects. The authors acknowledge the need for replication in larger, double-blind, randomized controlled studies to confirm these preliminary findings and establish more robust therapeutic protocols for the treatment of vulvodynia with acupuncture.